Ainos (NASDAQ:AIMD) reported a pivotal fiscal year 2025, characterized by a roughly 499% surge in revenue and a successful transition into high-volume industrial markets.
The company, which specializes in "SmellTech" digitization, saw its gross margin swing from a loss in 2024 to a positive 82.9% in 2025, reflecting the commercial maturation of its proprietary AI Nose platform.
The financial recovery was bolstered by a New Taiwan Dollar 90 million financing (approximately $2.82 million) secured in March 2026.
This capital injection is earmarked to support a scaled rollout of its sensing systems within the semiconductor sector.
Management confirmed that early 2026 operations are already underway, including the targeted installation of 200 front-end systems for technical validation in wafer fabrication facilities.
A central pillar of the company’s growth strategy is a three-year, $2.1 million subscription program for 1,400 back-end semiconductor systems.
Ainos has already received initial customer deposits for this phase and outlined a broader strategic roadmap that contemplates expanding the deployment to as many as 20,000 systems.
Analysts suggest such a scale could represent an annual subscription value approaching $10 million if fully realized.
Beyond hardware, Ainos is focusing on the monetization of its "Smell ID" data and the "Smell Language Model" (SLM).